Virchow Foundation: Lucy Gilson and Johan Rockström awarded the Virchow Prize 2024
Prize under High Patronage of the President of the German Bundestag endowed with 500,000 € for significant contributions towards safeguarding human and planetary health

Berlin, July 15, 2024 –The Virchow Prize 2024 will be bestowed upon Lucy Gilson and Johan Rockström for their holistic and systems-based approach to safeguarding human and planetary health.
Both laureates share a common focus on human well-being and sustainability, recognising that health systems are connected to, influence and depend on environmental and social systems. Gilson and Rockström are collectively advancing a more resilient, healthier, safe and just world, upholding the Virchow Prize’s values of human rights, solidarity, and equity in context of attaining the United Nations 2030 Agenda Sustainable Development Goals.
Lucy Gilson heads the Health Policy and Systems Division at Cape Town University, South Africa, and serves as Professor of Health Policy and Systems at the London School of Hygiene and Tropical Medicine, UK. Gilson’s research drives transformative change towards more sustainable, resilient and just governance, whilst advocating for people-centred health system and translating strategy into tangible improvements on the ground through innovative and consistent approaches. She has fostered substantial progress towards universal health coverage and equitable access to quality healthcare.
Johan Rockström leads the Potsdam Institute for Climate Impact Research, Germany, holds a professorship at Stockholm University, Sweden, and serves as Chief Scientist of Conservation International, United States. Rockström’s pioneering work revolves around the planetary boundaries framework, which defines the safe operating space for humanity to thrive sustainably and responsibly for future generations. This concept addresses critical processes such as climate change, biodiversity loss, freshwater use, and nutrient cycles, highlighting its direct relevance to health.
Gilson’s and Rockström’s advocacy for a holistic and systemic approach to health has influenced global policy and provides a science-based framework for tackling diverse health challenges globally. Both demonstrate that significant progress can be achieved through interdisciplinary, cross-sectoral research towards the common goal “Health for All”.
Established by the non-profit Virchow Foundation, the Virchow Prize is awarded annually. The 2024 Award Ceremony under high patronage of German Bundestag President, Bärbel Bas, will be held on October 12 at Berlin City Hall. More information: virchowprize.org
For media representatives
Virchow Prize 2024 Award Ceremony accreditation for media representatives is open until October 10, 2024: virchowprize.org/communications-kit/
Contact
Steffi Gasteiger (she/her)
Communication & Partnerships Manager
Virchow Foundation
press@virchow.foundation
T: +49 152 28251093
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
New record achieved: NTT DATA Business Solutions exceeds the previous year’s top figures in terms of both revenue and results12.5.2025 11:12:03 CEST | Press release
2024/2025 saw a double-digit revenue growth of 14.7 percent to 1.85 billion euros EBIT in three digits for the first time at 109.9 million euros (+35.9%) Close to a 50 percent increase in cloud subscriptions Proportion of international business tops 60 percent mark Optimistic outlook despite global uncertainties
Biomay Launches FDA-Grade CRISPR/Cas9 Nuclease for Off-the-Shelf Purchase9.5.2025 12:00:00 CEST | Press release
(Vienna, Austria) Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its off-the-shelf product portfolio for genome-editing applications. Clients purchasing Biomay´s Cas9 will benefit from the company´s unparalleled track record and expertise as a market-registered GMP-manufacturer of the nuclease. Biomay is the FDA-approved manufacturer of recombinant Cas9 as the essential component of CASGEVY®, the very first CRISPR genome editing product on the market. Biomay’s Cas9 (internal code “BMC9”) is based on the classical wild-type Cas9 nuclease from Streptococcus pyogenes. The Cas9 manufacturing process has been de novo developed, GMP-implemented and PPQ-validated by Biomay. GMP and RUO manufacturing is performed by fermentation with E. coli and by purification with chromatographic methods. By quality control with a comprehensive set of validated analytical assays, the consistent
mAInthink GmbH: Technological Breakthrough: Hallucination-Free Superintelligence Achieves 99.99% Strategic Accuracy – Germany Gains Permanent Strategic Superiority9.5.2025 10:57:00 CEST | Press release
Worms, May 9, 2025 – The mAInthink GmbH has achieved a technological breakthrough that redefines the future of strategic decision-making: With the development of StratePlan, a hallucination-free superintelligence delivering verified 99.99% strategic accuracy, Germany secures permanent technological, economic, and geopolitical superiority – operationally deployable and scientifically validated.
HEIDELBERG/Amperfied presents new DC fast charging solution with comprehensive range of services: Focus on dynamic power distribution and high availability7.5.2025 08:56:00 CEST | Press release
Offer is aimed at the increasing demand from charging parks, logistics depots and haulage fleets Amperfied addresses demand for fast charging system solutions with new DC product and performance-based offering DC becomes part of an availability-based operating hours model Modular technology for optimum utilization of the charging system and small footprint Debut at the Power2Drive 2025 Amperfied GmbH, a subsidiary of Heidelberger Druckmaschinen AG (HEIDELBERG), is entering the market for fast charging solutions complete with a comprehensive range of services. At the Power2Drive trade fair in Munich, the company will unveil its modular DC fast charging solution called Amperfied Dynamic DC, which focuses on availability and efficiency. The offering is aimed primarily at the growing demand from charging parks, logistics depots and haulage fleets for high-availability system solutions. This is because only with fast and functional charge points can charging infrastructure operators (CPOs)
HEIDELBERG holds its ground in a difficult market environment in FY 2024/25 - targets achieved, significant increase in incoming orders compared to previous year6.5.2025 08:52:59 CEST | Press release
Sales and adjusted EBITDA margin at previous year's level according to preliminary figures Free cash flow excluding special items clearly positive at around € 50 million Rising order intake compared to previous year lays the foundation for a good start to FY 2025/26 Additional, positive order impetus expected from China Print trade fair in May Adjusted EBITDA margin to rise to around 8 percent in FY 2025/26
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom